Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization

American Journal of Ophthalmology

Volumn 134, Issue 4, 2002, Pages 566-576

  Rogers, Adam H ^a   Martidis, Adam ^a,b   Greenberg, Paul B ^a,c   Puliafito, Carmen A ^a,c,d  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WILLS EYE HOSPITAL   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ARTICLE; CONTROLLED STUDY; EXAMINATION; EYE; EYE INJURY; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; OCULAR FIBROSIS; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA; RETINA FOVEA; RETINA MACULA DEGENERATION; RETINA MACULA EDEMA; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION;

BODY FLUIDS; CHOROIDAL NEOVASCULARIZATION; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; FIBROSIS; FLUORESCEIN ANGIOGRAPHY; HUMANS; OPTICS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETINA; RETROSPECTIVE STUDIES; TOMOGRAPHY;

EID: 0036808099     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)01566-0     Document Type: Article

References (14)

1. Klein R., Klein B.E.K., Linton K.L.P. Prevalence of age-related maculopathy the Beaver Dam eye study . Ophthalmology. 99:1992;933-943.
2. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials - TAP report 1. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Arch Ophthalmol. 117:1999;1329-1345.
3. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. two-year results of 2 randomized clinical trials- TAP report 2. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Arch Ophthalmol. 119:2001;198-207.
4. Roberts W.G., Hasan T. Role of neovasculature permeability on the tumor retention of photodynamic agents. Cancer Res. 52:1992;924-930.
5. Weishaupt K.R., Gomer C.J., Dougherty T.J. Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of a murine tumor. Cancer Res. 36:1976;2326-2329.
6. Henderson B.W., Dougherty T.J. How does photodynamic therapy work? Photochem Photobiol. 55:1992;145-157.
7. Moan J., Peng Q., Evensen J.F., et al. Photosensitizing efficiencies, tumor, and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem Photobiol. 46:1987;713-721.
8. Rosenthal I. Phthalocyanines as photosensitizers. Photochem Photobiol. 53:1991;859-870.
9. Henderson B.W., Donovan J.M. Release of prostaglandin Eqn. 2 from cells by photodynamic treatment in vitro. Cancer Res. 49:1989;6896-6900.
10. Puliafito C.A., Hee M.R., Lin C.P., et al. Imaging of macular disease with optical coherence tomography. Ophthalmology. 102:1995;217-229.
11. Massin P., Vicaut E., Haouchine B., et al. Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol. 119:2001;1135-1142.
12. Fukuchi T., Takahashi K., Uyama M., Matsumura M. Comparative study of experimental choroidal neovascularization by optical coherence tomography and histopathology. Jpn J Ophthalmol. 45:2001;252-258.
13. Fukuchi T., Takahashi K., Shou K. Optical coherence tomography (OCT) findings in normal retina and laser-induced choroidal neovascularization in rats. Graefes Arch Clin Exp Ophthalmol. 239:2001;41-46.
14. Schuitmaker J.J., Vrensen G.F.J.M., van Delft J.L., et al. Morphologic effects of bacteriochlorin a and light in vivo on intraocular melanoma. Invest Ophthalmol Vis Sci. 32:1991;2683-2688.